Structured evidence table for Selenium Hair Loss Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Selenium Hair Loss Randomized Trial | This systematic review aimed to evaluate the role of maternal Se status during pregnancy in miscarriage risk. | 1 | Kyriakou SI (2026) | The Impact of Selenium Exposure During Pregnancy on Risk for Miscarriage: A Systematic Review. |
| Selenium Hair Loss Randomized Trial | Available evidence was qualitatively synthesized and predefined sources of bias were assessed. | 1 | Kyriakou SI (2026) | The Impact of Selenium Exposure During Pregnancy on Risk for Miscarriage: A Systematic Review. |
| Selenium Hair Loss Randomized Trial | Despite notable methodological limitations across several studies, current evidence indicates that maternal blood Se concentrations are lower among women who experience miscarriage compared to those with uncomplicated pregnancies. | 1 | Kyriakou SI (2026) | The Impact of Selenium Exposure During Pregnancy on Risk for Miscarriage: A Systematic Review. |
| Selenium Hair Loss Randomized Trial | Selenium (Se) is an antioxidant essential trace element influencing inflammatory and immune pathways. | 1 | Kyriakou SI (2026) | The Impact of Selenium Exposure During Pregnancy on Risk for Miscarriage: A Systematic Review. |
| Selenium Hair Loss Randomized Trial | Clinical trial records were excluded from this figure to avoid combining completed published evidence with ongoing or unpublished investigations. | 3 | Mavandi Matthew (2026) | Pharmacotherapeutic Interventions for Sensorineural Hearing Loss: A Scoping Review |
| Selenium Hair Loss Randomized Trial | The ACCL0431 study and the SIOPEL-6 trial both demonstrated that delayed infusion of STS significantly reduced the incidence and severity of cisplatin-induced hearing loss in pediatric patients [,,]. | 3 | Mavandi Matthew (2026) | Pharmacotherapeutic Interventions for Sensorineural Hearing Loss: A Scoping Review |
| Selenium Hair Loss Randomized Trial | Taken together, these findings suggest that antioxidant therapy remains a promising but clinically heterogeneous approach, with the strongest current evidence supporting sodium thiosulfate for cisplatin-induced ototoxicity prevention. | 3 | Mavandi Matthew (2026) | Pharmacotherapeutic Interventions for Sensorineural Hearing Loss: A Scoping Review |
| Selenium Hair Loss Randomized Trial | 1 2 3 4 5 6 7 8 9 Sensorineural hearing loss (SNHL) is the most common type of permanent hearing loss, caused by damage to the inner ear or auditory pathways []. | 3 | Mavandi Matthew (2026) | Pharmacotherapeutic Interventions for Sensorineural Hearing Loss: A Scoping Review |
Source documents